Jain is trying to build the biological datasets needed to improve how women’s symptoms are understood and treated.
Priyanka Jain is co-founder and CEO of Evvy, a women’s-health company focused on vaginal microbiome testing and care. She came to the work through data-driven product development and an interest in the gaps in medical knowledge about female biology.
Product Work Before Evvy
She earned a bachelor’s degree at Stanford University, where she was a Mayfield Fellow and president of Stanford Women in Business. Evvy’s official biography describes her previous role as head of product at pymetrics, where she worked on algorithms intended to improve hiring decisions.
That experience connects to her later emphasis on the data behind a decision. In healthcare, Jain has focused on what cannot be learned when female biology has not been measured adequately, and on how new data can change the questions researchers and clinicians ask.
Building Evvy With Laine Bruzek and Pita Navarro
Jain launched Evvy in 2021 with Laine Bruzek and Pita Navarro. The company developed an at-home vaginal swab test and a service connecting results with clinician review and eligible prescription care. Its research also examines relationships among the microbiome, symptoms, interventions, and outcomes.
In a September 2026 TechCrunch interview, Jain put the research problem plainly: “You can’t build precision medicine for women on datasets that never adequately measured female biology in the first place.” Her aim is to connect testing with an expanding body of evidence, including work on fertility and recurrent symptoms.
Connecting AI With Biological Data
Evvy introduced an AI advisor in May 2026 to explain microbiome information and direct users to clinicians for questions requiring expert judgment. Jain’s argument for the tool begins with the underlying biological data, not just a conversational interface.
In the same TechCrunch interview, she described AI as a way to find patterns across symptoms, treatments, hormones, and other measurements that medicine has struggled to connect. Her longer-term ambition is an accessible at-home sample that can provide more regular information across women’s health, an area in which Evvy is still developing its research.